Indiana Nanotech Report issue

For profit Phase 1
Founded: Indianapolis IN United States (2006)
Status: No NME R&D (2006)

Organization Overview

First Clinical Trial
2010
NCT01094210
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Alternative names

Indiana Nanotech, LLC

Active Ingredients

Drugs in Phase 1 Trials (1)

sodium fluoride (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dental Caries (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 2
  • # of Trial APIs: 1